This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Patients with bronchiectasis in whom investigation should be considered

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

People who require investigations for bronchiectasis

Investigation for bronchiectasis should be considered in the following patients:

  • in children with
    • productive (sometimes non productive) chronic cough specially seen between viral colds
    • asthma who has poor response to therapy
    • unexplained haemoptysis
    • recurrent pneumonia
    • pertussis like illness which fails to resolve after 6 months
    • persistent and unexplained physical signs or chest radiographic abnormalities (1)
  • in adults with
    • persistent productive cough specially with
      • daily production of large amount of very purulent sputum
      • presentation at a young age
      • symptoms for many years
      • sputum positive for Pseudomonas aeruginosa
      • no history of smoking
    • unexplained haemoptysis and non productive cough
    • suspected COPD patients (alone or in addition to bronchiectasis) with no history of smoking, recurrent exacerbation or who is slow to recover from lower respiratory tract infection (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.